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Abstract – Streptococcus uberis and Serratia marcescens are Gram-positive and Gram-negative
bacteria, respectively, that induce clinical mastitis. Once initial host barrier systems have been
breached by these pathogens, the innate immune system provides the next level of defense against
these infectious agents. The innate immune response is characterized by the induction of pro-
inflammatory cytokines, as well as increases in other accessory proteins that facilitate host
recognition and elimination of the pathogens. The objective of the current study was to characterize
the innate immune response during clinical mastitis elicited by these two important, yet less well-
studied, Gram-positive and Gram-negative organisms. The pro-inflammatory cytokine response
and changes in the levels of the innate immune accessory recognition proteins, soluble CD14
(sCD14) and lipopolysaccharide (LPS)-binding protein (LBP), were studied. Decreased milk
output, induction of a febrile response, and increased acute phase synthesis of LBP were all
characteristic of the systemic response to intramammary infection with either organism. Infection
with either bacteria similarly resulted in increased milk levels of IL-1β, IL-8, IL-10, IL-12, IFN-γ,
TNF-α, sCD14, LBP, and the complement component, C5a. However, the duration of and/or
maximal changes in the increased levels of these inflammatory markers were significantly different
for several of the inflammatory parameters assayed. In particular, S. uberis infection was
characterized by the sustained elevation of higher milk levels of IL-1β, IL-10, IL-12, IFN-γ, and
C5a, relative to S. marcescens infection. Together, these data demonstrate the variability of the
innate immune response to two distinct mastitis pathogens.
cytokines / innate immunity / mastitis / Serratia / Streptococcus
1. INTRODUCTION 
Mastitis is an inflammation of the mam-
mary gland and remains one of the most
costly diseases to animal agriculture [50].
Economic losses attributed to this disease
are estimated to approach 2 billion dollars
annually in the USA alone [35]. Mastitis
most commonly results following the pas-
sage of pathogenic bacteria through the streak
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canal barrier of the teat where these organ-
isms gain access to the gland and establish
infection [47]. The ensuing inflammatory
response that accompanies bacterial entry
into the gland is highly variable and can dic-
tate whether a pathogen is quickly elimi-
nated or successfully establishes infection.
Serratia spp. have been implicated in
bovine mastitis and in two reports have been
estimated to account for approximately 9–
12% of all naturally acquired Gram-nega-
tive bacterial infections [19, 56]. Of those
species of Serratia that cause mastitis, S.
marcescens is the most prevalent [55]. Ser-
ratia spp. have been isolated from water,
soil, feed, and bedding materials [67], and
in at least one report, herd outbreaks of Ser-
ratia have been attributed to contaminated
teat dips [60]. Cows with Serratia intramam-
mary infections (IMI) typically display mild
clinical symptoms with the subclinical form
of infection being more characteristic than
for IMI’s caused by other Gram-negative
bacteria [55]. Serratia IMI also tend to
become chronic with a mean duration of
infection lasting > 160 days. The mild clin-
ical symptoms displayed during Serratia
IMI, as well as, the finding that this patho-
gen is shed in low numbers complicates the
ability to identify Serratia as a causative
agent of mastitis during outbreaks [6]. Of
perhaps greater concern is that Serratia iso-
lates from cases of mastitis are reportedly
resistant to most approved antibiotics [6, 60].
Among the environmental Streptococ-
cus spp. that cause mastitis, S. uberis is the
most prevalent [62]. In one study, the per-
centage of all IMI’s attributed to S. uberis
was reported to range from 12–16% [21].
Other studies have implicated this pathogen
as the causative agent of clinical mastitis in
13–20% of all cases [8, 64]. S. uberis has
been recovered from soil, bedding materi-
als, feces, as well as, various anatomical
regions of the cow [7, 8]. Similar to S. marc-
escens infections, IMI’s caused by S. uberis
are predominantly subclinical and can per-
sist for long periods of time in a chronic
state [21, 22, 40]. Currently recommended
antibiotic therapy in the USA for S. uberis
IMI remains sub-optimal as two-day treat-
ment with pirlimycin was recently reported
to eliminate only 58% of infections [38].
Innate immune recognition of bacteria is
mediated, in part, by Toll-like receptors
(TLR’s). TLR-2 recognition of peptidogly-
can [66] and lipoteichoic acid [33, 48] and
TLR-4 recognition of bacterial lipopoly-
saccharide (LPS) [16] contribute to the abil-
ity of the innate immune system to respond
to Gram-positive and Gram-negative bac-
teria, respectively. Activation of these dis-
tinct TLR’s by Gram-positive and Gram-
negative cell wall products is characterized
by differential gene expression and cellular
responses [3, 36, 43]. 
Staphylococcus aureus and Escherichia
coli, Gram-positive and Gram-negative path-
ogens, respectively, elicit differential mam-
mary gland innate immune responses [5,
45]. Relative to S. aureus, E. coli IMI is
accompanied by a heightened inflamma-
tory response characterized by sustained
production of IL-8 and TNF-α, complement
activation, and enhanced mammary vascu-
lar permeability. Whether the lack of such
a pronounced pro-inflammatory cytokine
response during S. aureus IMI is specific to
IMI’s by S. aureus or is characteristic of all
Gram-positive IMI’s remains unknown. The
objective of the current study was to char-
acterize the innate immune response to IMI
with either S. marcescens or S. uberis and to
determine whether the inflammatory cytokine
response elicited by either of these organ-
isms is comparable to that previously reported
for E. coli and S. aureus (i.e., whether there
are conserved cytokine responses among
Gram-positive and/or Gram-negative organ-
isms). In addition, we studied changes in the
intramammary concentrations of two acces-
sory molecules, soluble CD14 (sCD14) and
LPS-binding protein (LBP), which facili-
tate host innate recognition of bacterial cell
wall products.
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2. MATERIALS AND METHODS
2.1. Cows 
A pool of 15 healthy, mid-lactating Hol-
stein cows (185 ± 9 DIM) were selected
from the USDA National Animal Disease
Center’s dairy herd (Ames, Iowa, USA) on
the basis of milk somatic cell counts (SCC)
of < 200 000 cells/mL and the absence of
detectable bacteria growth from aseptically
collected milk samples plated on blood
agar. The use and care of all animals in this
study was approved by the National Animal
Disease Center’s Animal Care and Use
Committee.
2.2. Intramammary challenge 
with S. uberis or S. marcescens
Prior to intramammary challenge, 10 mL
of brain heart infusion broth (Becton-Dick-
inson Diagnostic Systems, Inc., Sparks, MD,
USA) were inoculated with either S. marc-
escens (gift of Dr K. Larry Smith; Ohio State
University, Wooster, OH, USA) or S. uberis
strain 0140 (gift of Dr A.J. Bramley, Insti-
tute for Animal Health, Compton Labora-
tory, Newbury, England) and incubated over-
night at 37 °C. The bacteria were subsequently
pelleted by centrifugation, resuspended in
PBS, aliquotted, and frozen. Prior to chal-
lenge, representative aliquots were thawed,
serially diluted, and spread on blood agar
plates. Following an overnight incubation at
37 °C, the concentrations of the frozen stock
aliquots were calculated. For preparation of
the inoculum used for intramammary infu-
sion, frozen aliquots were diluted in PBS to
yield a final approximate concentration of
100 CFU/mL. 
In an initial experiment, 10 cows were
infused with 2 mL of the prepared inoculum
of S. marcescens in one quarter immedi-
ately following the morning milking. The
contralateral quarter of each infected quar-
ter was infused with 2 mL of PBS. Seven
days after challenge, two cows were euth-
anized for the harvesting of tissue while the
remainder of the cows were sampled for an
additional two weeks. In a subsequent exper-
iment, 12 cows were infused as above with
either PBS or S. uberis. All S. uberis-infected
cows developed severe clinical mastitis and
distress resulting in the termination of the
study at day 7 (168 h) and the initiation of
palliative care. Post-plating of the final pre-
pared inoculums that were infused con-
firmed that cows received 260 or 220 CFU/
quarter of S. marcescens or S. uberis, respec-
tively. Following challenge, aseptic milk
samples were collected from all infused quar-
ters at various time points, serially diluted,
and plated on blood agar plates. Following
a 16 h incubation at 37 °C, CFU/mL were
determined. Colonies were initially identi-
fied as either S. marcescens or S. uberis
based on morphological characteristics. Fur-
ther biochemical tests and gas chromatog-
raphy were performed by the Maryland
Department of Agriculture Animal Health
Section (College Park, MD, USA) to con-
firm initial identification.
2.3. Determination of milk somatic cell 
and total white blood cell (WBC) 
counts 
To quantitate somatic cells, milk sam-
ples were heated to 60 °C and subsequently
maintained at 40 °C until counted on an auto-
mated cell counter (Fossomatic model 90,
Foss Food Technology, Hillerod, Denmark)
as previously described [32]. For the deter-
mination of circulating WBC counts, jugu-
lar vein blood samples were collected in Vacu-
tainer® glass tubes containing sodium heparin
(Becton-Dickinson Corp., Franklin, Lakes,
NJ, USA) and diluted 1:250 in Isoton II
diluent (Beckman Coulter Corp., Fullerton,
CA, USA). Six drops of Zap-oglobin II lytic
(Beckman Coulter Corp.,) reagent were
added to the diluted samples and cells
counted using a Nova Celltrak 2 cell counter
(Angel Engineering Corp., Trumbull, CT,
USA) using a threshold setting of 6.8.
2.4. Whey and plasma preparation
For the preparation of whey, milk sam-
ples were centrifuged at 44 000 × g at 4 °C
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for 30 min and the fat layer removed with
a spatula. The skimmed milk was decanted
into a clean tube and centrifuged again for
30 min as above and the translucent super-
natant collected and stored at –70 °C. For
the preparation of plasma, heparinized jug-
ular vein blood samples were collected as
above, centrifuged at 1 500 × g for 15 min,
and the clear plasma supernatant collected,
aliquotted, and stored at –70 °C. 
2.5. Enzyme-linked immunosorbent 
assays (ELISA’s)
ELISA’s for BSA, C5a, IFN-γ, IL-1β,
IL-8, IL-10, IL-12, LBP, sCD14, and TNF-α,
were all performed as previously described
[4, 5]. Milk and plasma samples collected
from S. marcescens- and S. uberis-infected
cows were all assayed by any given ELISA
in parallel on the same day using the same
known standards.
2.6. Statistical methods
Repeated measures ANOVA was per-
formed using the PROC MIXED model (SAS
8.2; SAS Institute, Cary, NC, USA) to com-
pare the mean responses between experi-
mental groups and the pre-infused (time 0)
groups. For statistical analysis of milk SCC,
data were transformed to log10 values. An
unpaired t-test (GraphPad Prism version 4.0
for Windows; GraphPad Software Inc., San
Diego, CA, USA) was used to compare the
maximal responses elicited by S. uberis and
S. marcescens in a given experimental assay.
A P-value of < 0.05 was considered signif-
icant.
3. RESULTS
3.1. Bacterial recovery from infected 
quarters
To determine whether initial infusion of
S. marcescens (260 CFU/quarter) or S. uberis
(220 CFU/quarter) resulted in the establish-
ment of infection, aseptic milk samples
were collected at varying time points fol-
lowing infusion. Milk samples were col-
lected from all challenged quarters through-
out the first 7 days (168 h) of the study.
After day 7, two cows that had originally
been challenged with S. marcescens were
euthanized for the harvesting of tissue for
future analysis. Due to the development of
severe clinical mastitis and distress in all
cows challenged with S. uberis, antibiotic
treatment was initiated in these cows at day
7 resulting in termination of the study. 
Within 6 h of and up to 96 h following
challenge, viable bacteria were recovered
from all ten quarters infused with S. marc-
escens (Fig. 1A). Transient decreases in the
number of quarters from which viable
S. marcescens were recovered occurred at
168 and 336 h post-infection, however, by
day 21 (504 h) viable bacteria were recov-
ered from all challenged quarters. In con-
trast, viable bacteria were not recovered
from all quarters infused with S. uberis until
24 h post-infection. Once viable S. uberis
was recovered from an infected quarter, the
quarter remained infected until the end of
the study (i.e., 168 h post-infection). 
Comparable numbers of S. marcescens
(3.82 ± 0.18 log10 CFU/mL) and S. uberis(3.97 ± 0.36 log10 CFU/mL) were recov-
ered from infected glands within 12 and 18 h,
respectively, of challenge (Fig. 1B). After
reaching a peak at 12 h post-inoculation, the
number of CFU’s of S. marcescens recovered
from infected quarters declined until 24 h,
after which the levels remained constant at
~ 2.5 log10 CFU/mL. In contrast, the number
of CFU’s recovered from S. uberis infected
quarters continued to increase throughout
the study reaching a peak (7.84 ± 0.26 log10
CFU/mL) at 168 h.
3.2. Systemic response to 
intramammary infection with 
either S. marcescens or S. uberis
Daily milk output consisting of the sum
of both the morning and evening milk
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weights of cows infected with S. marces-
cens dropped on day 0, reflecting a decrease
in evening milk production 12 h after infu-
sion (Fig. 2A). Within 1 day following
S. marcescens or 2 days following S. uberis
challenge, comparable decreases of ~ 35%
in milk production relative to pre-challenge
levels were observed. At > 2 days of chal-
lenge, milk production returned to normal
in cows infected with S. marcescens, whereas,
milk output remained depressed throughout
the study in those cows infected with S.
uberis. 
In cows challenged with S. marcescens,
a febrile response was first observed at 12 h
post-infection, peaked 6 h later, and returned
to baseline levels by 36 h (Fig. 2B). In contrast,
elevated temperatures were not detected until
30 h post-infection with S. uberis, after which
the temperatures remained elevated through-
out the study. The sustained elevation in
Figure 1. Recovery of viable Serratia marcescens or Streptococcus uberis following experimental
intramammary infection. Following intramammary infusion of one quarter on each of 10 cows with
260 CFU of S. marcescens or one quarter on each of 12 cows with 220 CFU of S. uberis, milk samples
were aseptically collected from all infused quarters at various time points and spread on blood agar
plates. S. uberis infected cows were followed out until 168 h, whereas, those infected with S. marces-
cens were followed out for a total of three weeks (504 h). The percent of quarters from which viable
bacteria were recovered is indicated (A). In quarters from which bacteria were recovered, the mean
(± S.E.) of log10 CFU/mL is shown (B). 
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temperature over several days following IMI
with S. uberis is consistent with that of a
previous report [17]. Peak elevations in
body temperatures were comparable among
cows receiving either S. marcescens (39.96 ±
0.28 °C) or S. uberis (39.81 ± 0.26 °C). The
ability of either pathogen to elicit a systemic
response was further demonstrated by an
increase in circulating levels of LBP, a
hepatically-derived protein whose expres-
sion is upregulated during the acute phase
response to infection [49]. Circulating lev-
els of LBP initially increased within 24 or
30 h of infection with either S. marcescens
or S. uberis, respectively, and remained ele-
vated for ≥ 7 days from the start of the study
(Fig. 3). Peak levels of plasma LBP (99.34 ±
6.18 µg/mL) detected 72 h following S. uberis
infusion, were significantly higher than the
peak levels (77.55 ± 5.28 µg/mL) observed
36 h post-challenge with S. marcescens
(P = 0.016).
Figure 2. Effect of intramammary infection with Serratia marcescens or Streptococcus uberis on
milk production and core body temperature. Total daily milk weights (sum of morning and evening
outputs) were collected for 3 days prior to and until 6 days after intramammary infusion on day 0
(A). *, # Significantly decreased compared to pre-challenge levels (day –1) in cows challenged with
S. marcescens or S. uberis, respectively (P < 0.05). As an indicator of a systemic response, rectal
temperatures were measured immediately prior to and at various time points following intramam-
mary infection (B). *, # Significantly increased compared to time 0 in cows challenged with S. marc-
escens or S. uberis, respectively (P < 0.05). 
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3.3. Intramammary infection 
with either S. marcescens 
or S. uberis is characterized 
by decreases in circulating WBC 
and elevations of milk SCC
Decreased numbers of total circulating
WBC’s were evident within 18 h of S. marc-
escens challenge and six hours later reached
a minimum of 7 070 ± 650 cells/µL
(Fig. 4A). Within 36–48 h of infection, a
transient increase in circulating WBC’s rel-
ative to time 0 was observed in S. marces-
cens infected cows. In contrast, initial
decreases in circulating WBC’s in cows
challenged with S. uberis were not observed
until 36 h after infection and remained sig-
nificantly decreased between 60 and 96 h
following infection. There was no differ-
ence in the minimum levels of circulating
WBC’s detected following infection with
either bacteria.
Increases in milk somatic cells, which
are primarily composed of neutrophils dur-
ing the acute phase of infection [46], were
evident within 18 and 30 h of S. marcescens
or S. uberis challenge, respectively (Fig. 4B).
Maximal numbers of milk SCC were observed
at 36 or 60 h following S. marcescens or
S. uberis challenge, respectively, and the
magnitude of the peak SCC did not statis-
tically differ between quarters infected with
either organism. Milk SCC in all infected
quarters remained elevated relative to pre-
challenge levels throughout the study. Milk
SCC in saline control quarters did not change
over the course of the study (data not shown). 
3.4. Intramammary infection 
with S. marcescens or S. uberis 
elicits an increase in mammary 
vascular permeability
As an indicator of changes in mammary
vascular permeability, milk levels of BSA
were quantified by ELISA. Milk from quar-
ters infused with S. marcescens demon-
strated an acute increase in levels of BSA
within 18 h of infection and elevated levels
persisted for an additional 18 h (Fig. 5).
Increases in milk BSA levels in S. uberis
infected quarters were not detected until 30 h
after challenge and remained augmented
throughout the study. Maximal increases in
BSA levels did not statistically differ between
quarters infected with either bacterium.
Figure 3. Changes in the circulating levels of LPS-binding protein (LBP) following intramammary
infection with Serratia marcescens or Streptococcus uberis. LBP levels in plasma prepared from
blood collected immediately prior to and at various time points following intramammary infection
were assayed by ELISA. *, # Significantly increased compared to time 0 in cows challenged with
S. marcescens or S. uberis, respectively (P < 0.05). 
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3.5. Differential changes in the levels 
of the chemoattractants IL-8 and 
C5a following intramammary 
challenge with either S. marcescens 
or S. uberis
Intramammary infection with S. marces-
cens induced transient increases in the milk
concentrations of IL-8 and C5a, whereas
S. uberis challenge resulted in a more sus-
tained increase in milk IL-8 and C5a (Fig. 6).
At time points in which IL-8 levels were
significantly elevated relative to time 0, there
was no statistical difference in the maximal
levels of IL-8 detected in milk from quarters
infected with either organism. However, the
mean peak concentrations of C5a following
S. uberis infection (45.56 ± 3.77 ng/mL) were
significantly higher than those reached in
S. marcescens infected quarters (5.92 ±
2.76 ng/mL) (P < 0.0001). Strikingly, the
C5a levels in milk from S. uberis infected
quarters continued to increase throughout
the infection in contrast to the C5a levels
in the S. marcescens quarters that quickly
returned to baseline.
Figure 4. Effect of intramammary infection with Serratia marcescens or Streptococcus uberis on
total circulating white blood cells (WBC) and milk somatic cell counts (SCC). Total WBC counts
were determined from blood samples collected immediately prior to and at various time points fol-
lowing intramammary infection (A). *, # Significantly different compared to time 0 in cows chal-
lenged with S. marcescens or S. uberis, respectively (P < 0.05). Milk SCC were quantified in milk
samples collected from infected quarters throughout the study (B). *, # Significantly increased in
S. marcescens- or S. uberis-infected quarters, respectively, relative to time 0 (P < 0.05). 
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3.6. Differential temporal induction 
of TNF-α and IL-1β following 
intramammary challenge 
with either S. marcescens 
or S. uberis
Intramammary infection with either S.
marcescens or S. uberis induced increased
levels of TNF-α and IL-1β in milk (Fig. 7).
Increases in TNF-α in response to infection
with either organism were transient and
highly variable (Fig. 7A). Relative to time 0,
increases in TNF-α were observed in S. marc-
escens challenged quarters at 18 and 72 h
and in S. uberis infected quarters at 168 h.
Peak increases in TNF-α in S. marcescens
challenged quarters at 18h (11.24 ± 3.45 ng/
mL) were significantly higher than those in
S. uberis infected quarters at 168 h (2.54 ±
0.67 ng/mL) (P = 0.0127). A transient increase
in IL-1β was initially observed 18 h follow-
ing S. marcescens challenge and increased
again 78 h later, after which the levels
remained elevated until the end of the study.
IL-1β levels in S. uberis infected quarters
increased at 60 h and remained elevated
throughout the study. Maximal increases in
IL-1β following infection with either organ-
ism were observed 96 h post-challenge and
those in S. uberis infected quarters (1.81 ±
0.55 ng/mL) were significantly higher than
those in S. marcescens quarters (0.49 ±
0.053 ng/mL) (P = 0.0427).
3.7. S. marcescens or S. uberis infection 
elicits IL-12, IFN-γ, and IL-10 
production
Within 18 and 30 h of infection with either
S. marcescens or S. uberis, respectively,
initial and comparable increases in IFN-γ
levels were detected (Fig. 8A). IFN-γ levels
continued to increase in S. uberis infected
quarters, whereas, those in S. marcescens
infected quarters transiently decreased before
increasing again at 96 h. Relative to time 0,
maximal concentrations of IFN-γ that were
significantly increased in S. uberis quarters
were detected at 168 h (3.55 ± 1.36 ng/mL)
and these peak levels were significantly
higher than the maximal levels observed
in S. marcescens quarters at 24 h (0.16 ±
0.11 ng/mL) (P = 0.0345). 
In quarters infected with either bacteria,
elevated levels of IL-12 (Fig. 8B) were
observed temporally coincident with or
Figure 5. Intramammary infection with Serratia marcescens or Streptococcus uberis increases mam-
mary vascular permeability. As an indicator of changes in mammary vascular permeability, milk
BSA concentrations were assayed by ELISA in samples obtained from quarters immediately prior
to and at varying time points following intramammary infusion with S. marcescens or S. uberis.
*, # Significantly increased in S. marcescens- or S. uberis-infected quarters, respectively, relative
to time 0 (P < 0.05). 
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immediately following initial increases in
IFN-γ. Changes in IL-12 levels correlated
with those of IFN-γ in both S. uberis (r =
0.8) and S. marcescens (r = 0.93) infected
quarters. Similar to IFN-γ, maximal levels
of IL-12 measured in S. uberis infected
quarters (1 169 ± 117 biological units/mL)
exceeded those detected in quarters infected
with S. marcescens (77.16 ± 21.27 biolog-
ical units/mL) (P < 0.0001). 
Initial increases in the anti-inflammatory
cytokine IL-10 were observed in milk within
18 h of S. marcescens infection and returned
to pre-challenge levels > 18 h later
(Fig. 8C). In contrast, IL-10 levels initially
increased in S. uberis infused quarters 30 h
after infection and elevated levels persisted
from 42 h until the end of the study. Peak
levels of IL-10 in S. uberis-challenged quar-
ters (160.12 ± 32.86 biological units/mL)
were significantly higher than those detected
in quarters challenged with S. marcescens
(71.78 ± 14.64 biological units/mL) (P =
0.0328).
Figure 6. Effect of intramammary infection with Serratia marcescens or Streptococcus uberis on
milk concentrations of IL-8 and C5a. Milk concentrations of IL-8 (A) and C5a (B) in samples col-
lected from quarters immediately prior to and at varying time points following intramammary bac-
terial infection were assayed by ELISA. *, # Significantly increased in S. marcescens- or S. uberis-
infected quarters, respectively, relative to time 0 (P < 0.05). 
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3.8. Intramammary infection with 
S. marcescens or S. uberis augments 
milk levels of sCD14 and LBP
Changes in milk levels of sCD14 and
LBP, two proteins involved in host cell rec-
ognition of bacterial wall products, were
assayed by ELISA. Relative to pre-chal-
lenged quarters (time 0), increased levels of
milk sCD14 were evident within 36 or 48 h
of S. marcescens or S. uberis infusion, respec-
tively (Fig. 9A). Increased levels of sCD14
persisted in S. uberis infected glands until
the end of the study, whereas, those in S.
marcescens challenged quarters returned to
time 0 levels by 168 h. Maximal sCD14
concentrations observed 48 h after S. marc-
escens infection (11.00 ± 1.29 µg/mL) were
significantly higher than the peak levels
detected in S. uberis infected quarters at 72 h
(5.29 ± 0.81 µg/mL) (P = 0.0009). 
Increases in milk levels of LBP were
detected within 24 or 30 h of S. marcescens
Figure 7. Effect of Serratia marcescens or Streptococcus uberis infection on TNF-α and IL-1β con-
centrations in milk. ELISA’s were used to determine the concentrations of TNF-α (A) and IL-1β
(B) in milk obtained from quarters infected with S. marcescens or S. uberis. *, # Significantly
increased in S. marcescens- or S. uberis-infected quarters, respectively, relative to time 0 (P < 0.05). 
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Figure 8. Effect of intramammary infection with Serratia marcescens or Streptococcus uberis on
milk levels of IFN-γ, IL-12, and IL-10. Milk concentrations of IFN-γ (A), IL-12 (B), and IL-10 (C)
in samples collected from quarters infused with S. marcescens or S. uberis were assayed by ELISA.
*, # Significantly increased in S. marcescens- or S. uberis-infected quarters, respectively, relative
to time 0 (P < 0.05). 
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or S. uberis challenge, respectively (Fig. 9B).
Similar to sCD14, augmented levels of
LBP in S. uberis infected glands persisted
throughout the study, whereas, those in S.
marcescens challenged quarters returned to
pre-challenge levels by 168 h. LBP concen-
trations peaked within 36 or 60 h of S. marc-
escens (25.44 ± 1.96 µg/mL) or S. uberis
infection (22.22 ± 1.74 µg/mL), respec-
tively, and were comparable in magnitude.
Changes in LBP concentrations in milk cor-
related with those in plasma (Fig. 3) for both
S. marcescens (r = 0.9499) and S. uberis
(r = 0.9726) infected animals. 
4. DISCUSSION
The innate immune system via TLR’s
and other pattern recognition receptors is
poised to rapidly respond to the earliest
stages of infection [18]. The capability of
the innate immune system to respond to a
vast number of pathogens, which it may or
may not have previously encountered, is medi-
ated by its ability to recognize highly con-
served motifs shared by diverse pathogens.
Among the motifs recognized are the bac-
terial cell wall components, LPS, peptidog-
lycan, and lipoteichoic acid [1]. Recognition
Figure 9. Effect of intramammary infection with Serratia marcescens or Streptococcus uberis on
milk levels of sCD14 and LBP. sCD14 (A) and LBP (B) concentrations in milk obtained from quar-
ters infused with either S. marcescens or S. uberis were quantified by ELISA. *, # Significantly
increased in S. marcescens- or S. uberis-infected quarters, respectively, relative to time 0 (P < 0.05).
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of these bacterial cell wall components
often leads to the induction of a pro-inflam-
matory cytokine response that promotes
elimination of the infectious pathogen [13,
23, 53]. 
TNF-α and IL-1β are well-described
pro-inflammatory cytokines that mediate
the inflammatory response at both the local
and systemic levels [13, 54]. Locally, these
cytokines promote neutrophil recruitment
to the site of infection by acting as chemo-
attractants and by inducing the upregula-
tion of vascular adhesion molecules neces-
sary for neutrophil transendothelial migration.
Neutrophil recruitment to the site of infec-
tion is further mediated by the chemoat-
tractants IL-8 and C5a, a cytokine and com-
plement cleavage product, respectively [10].
Systemically, TNF-α and IL-1β are potent
inducers of fever and the acute phase response,
the latter of which is characterized by increased
hepatic synthesis of proteins such as LPS-
binding protein (LBP) and C-reactive pro-
tein (CRP) [59]. LBP and CRP facilitate
host detection of bacterial wall products and
complement activation, respectively. Other
important cytokines that are upregulated
during the inflammatory response to bacte-
rial infection include IL-12 and IFN-γ,
which contribute to both the innate and
adaptive immune responses by activating
neutrophils and macrophages and promot-
ing a Th1-type immune response [57]. Res-
olution of the inflammatory process is medi-
ated by IL-10 which downregulates pro-
inflammatory cytokine production [44, 52].
Together, cytokines mediate several aspects
of the innate immune response including
immune cell recruitment, activation, differ-
entiation, and downregulation. In the present
study, the cytokine response elicited by two
important mastitis pathogens, S. marces-
cens and S. uberis, was characterized.
Cows infected with either S. marcescens
or S. uberis developed clinical mastitis char-
acterized by the development of a febrile
response (Fig. 2B), induction of acute phase
hepatic synthesis (Fig. 3), changes in the
appearance of milk, and a marked decrease
in milk production (Fig. 2A). The changes
in milk appearance were consistent with the
detection of increased SCC in milk (Fig. 4B)
and the leakage of vascular components into
the gland (Fig. 5). Relative to S. uberis-
infected cows, the onset of systemic and
localized changes was more rapid in cows
challenged with S. marcescens. Equivalent
concentrations of viable bacteria were recov-
ered from S. marcescens and S. uberis infected
quarters within 12 and 18 h of infusion,
respectively (Fig. 1B). This 6 h lag in S. uberis
growth necessary to reach comparable lev-
els detected in S. marcescens quarters may
explain the delay in the onset of systemic
and localized changes. However, initial
changes in several parameters, including
increases in core body temperature, decreases
in total circulating WBC’s, increases in milk
SCC, breakdown of mammary vascular
barrier function, and increases in milk lev-
els of IL-8, TNF-α, IL-1β, IFN-γ, IL-10,
and sCD14 were delayed by ≥ 12 h in S.
uberis cows relative to those infected with
S. marcescens. The more rapid induction of
the innate immune response to S. marces-
cens may be attributed to LPS, a component
of the outer envelope of all Gram-negative
bacteria. LPS is a highly pro-inflammatory
molecule that is able to elicit a rapid innate
immune response in the mammary gland
[4]. Thus, the presence of LPS on S. marc-
escens and the TLR-4-mediated recogni-
tion of this molecule may contribute to the
rapid mobilization of host defense mecha-
nisms against this bacterium.
TNF-α and IL-1β are potent inducers of
fever and acute phase hepatic synthesis
[13]. Maximal increases in TNF-α and ini-
tial transient increases in IL-1β at 18 h
(Fig. 7) were temporally coincident with max-
imal increases in core body temperature in
cows infected with S. marcescens (Fig. 2B).
Similarly, initial increases in TNF-α and
IL-1β immediately preceded induction of
acute phase hepatic synthesis as evidenced
by increases in circulating LBP (Fig. 3), an
acute phase protein. Both the rapid induc-
tion in the expression of TNF-α and IL-1β
and the concentrations expressed are
Innate immunity during clinical mastitis 695
consistent with studies on IMI’s caused by
another Gram-negative bacterium, E. coli
[45]. In contrast to cows challenged with
S. marcescens, elevations in core tempera-
ture and heightened levels of circulating
LBP in S. uberis-infected cows preceded
detectable increases in these cytokines.
Increases in the production of TNF-α and
IL-1β in these cows at ≥ 60 h are consistent
with the findings of the only other report to
assay for these cytokines during S. uberis
IMI [42]. The induction of fever and acute
phase hepatic synthesis prior to increases in
TNF-α and IL-1β may be due to the upreg-
ulation of other cytokines such as IL-6,
which can similarly elicit these responses
[28, 31]. 
Increases in milk SCC (Fig. 4B) were
first detected 18 or 30 h after infusion of
S. marcescens or S. uberis, respectively,
and were temporally coincident with initial
increases in IL-8 and the complement
cleavage product C5a (Fig. 6), both of which
are chemoattractants [10]. The temporal
changes and elevated concentrations of IL-8
detected in S. marcescens-infected quarters
are similar to those reported following E. coli
infection [27, 51]. The transient increase in
C5a following challenge with S. marcescens
was of briefer duration than that reported
following E. coli IMI [45]. In comparison
to the only other study to directly measure
milk levels of IL-8 following S. uberis infec-
tion [42], the present study observed earlier
and enhanced increases in IL-8. These dif-
ferences may be explained by the different
strains (0140 vs. UT888) used in the two
studies.
Changes in milk C5a levels (Fig. 6B)
correlated with increased mammary vascu-
lar permeability, as evidenced by elevated
milk BSA levels (Fig. 5), in S. marcescens-
(r = 0.99) and S. uberis-infected (r = 0.76)
quarters. Since physiological levels of com-
plement proteins in milk are relatively low
[41], the current findings suggest that serum-
derived complement components leak into
infected quarters where complement becomes
activated.
During the acute stages of mastitis,
WBC’s can constitute > 90% of the milk
somatic cells present in infected quarters
[46]. Initial increase in milk SCC in S. marc-
escens infected cows paralleled decreases in
total WBC’s (Fig. 4). Similarly, the delayed
increases in milk SCC in S. uberis infected
quarters relative to those infected with S.
marcescens paralleled delayed decreases in
circulating total WBC’s. The initial increase
in milk SCC in S. uberis-infected quarters
at 30 h, however, was not accompanied by
a detectable decrease in circulating WBC’s.
Relative to S. marcescens-infected quarters,
the initial delay in recruitment of neu-
trophils to the mammary gland following
S. uberis infection may enable recruitment
from bone marrow stores of WBC’s over a
longer period of time, thus, precluding imme-
diate corresponding decreases in circulat-
ing neutrophils. 
IL-12 and IFN-γ play key roles in pro-
moting Th1 differentiation, activating mac-
rophages, and conferring overall resistance
to bacterial infections [2, 30]. Similar to
IL-8 and TNF-α, increases in IL-12 and
IFN-γ were detected at earlier time points in
S. marcescens-infected cows than in those
infused with S. uberis (Fig. 8). In contrast
to IL-8 and TNF-α, maximal levels of IL-12
and IFN-γ in S. uberis-infected quarters
exceeded those challenged with S. marces-
cens. In response to infection with either
bacteria, increases in IL-12 and IFN-γ cor-
related with one another, consistent with
reports that each cytokine is capable of stim-
ulating production of the other [11, 30, 34].
IL-10 is an anti-inflammatory cytokine that
downregulates pro-inflammatory cytokine
production, thus, contributing to the reso-
lution of the inflammatory response to
infection [12]. Resolution is essential in the
mammary gland as prolonged inflamma-
tion can elicit injury to the epithelial lining
of the gland resulting in permanent scarring
and decreased milk output [29, 39]. Rela-
tive to quarters infused with S. marcescens,
elevated levels of IL-10 persisted in S. uberis-
infected quarters throughout the study. This
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latter finding may reflect continued, but unsuc-
cessful attempts of the host to downregulate
the exuberant and possibly injurious inflam-
matory response elicited by S. uberis IMI.
Pathogen recognition by TLR’s initiates
a signal transduction cascade leading to
inflammatory and immune responses that
can potentially control and/or eliminate infec-
tious agents [58]. Recently, TLR-2 and
TLR-4 have been reported to be upregu-
lated in cows with mastitis induced by
Gram-positive and Gram-negative infec-
tions [15]. TLR-2 and TLR-4 recognition of
Gram-positive and Gram-negative cell wall
products is facilitated by the accessory mol-
ecules CD14 and LBP. CD14 exists in both
a membrane-associated and soluble form
[61]. LBP is a hepatically-derived acute phase
protein that enhances CD14/TLR recogni-
tion of bacterial cell wall products [49]. An
array of experimental approaches, includ-
ing the use of LBP–/– [14, 20] or CD14–/–
[65] mice, CD14 neutralizing antibodies [25,
63], and administration of exogenous LBP
[24] have established a protective role for
CD14 and LBP in mediating host responses
to LPS and Gram-negative bacterial infec-
tion. We have shown that exogenous recom-
binant bovine sCD14 enhances intramam-
mary clearance of E. coli in both mice [26]
and cattle [27]. CD14 and LBP have further
been shown to facilitate TLR-2 activation
by lipoteichoic acid and peptidoglycan derived
from Gram-positive bacteria [48, 66]. Thus,
sCD14 and LBP contribute to host recogni-
tion of and responses to both Gram-positive
and Gram-negative bacteria.
Intramammary challenge with either S.
marcescens or S. uberis resulted in increased
milk levels of both sCD14 and LBP (Fig. 9).
Similar to other responses, initial changes
in the concentrations of both of these pro-
teins were observed at earlier time points in
S. marcescens-infected animals. The increase
in the concentrations of both sCD14 and
LBP following infection would be expected
to be optimally beneficial since these pro-
teins act in concert to facilitate host recog-
nition of bacterial wall products. Initial
increases in IL-1β, IL-8, IL-10, IFN-γ, and
TNF-α in S. marcescens-infected quarters
preceded initial increases in LBP and
sCD14 at 24 and 36 h, respectively. This
finding suggests that the induction of initial
responses to S. marcescens may occur in the
presence of physiological levels of sCD14
and LBP. Interestingly, increases in sCD14
and LBP in S. uberis-infected quarters pre-
ceded initial increases in milk levels of IL-1β
and TNF-α. Whether elevated levels of sCD14
and LBP are necessary for the induction of
these pro-inflammatory cytokines during
Gram-positive infection remains unknown.
Increased concentrations of milk LBP
(Fig. 9B) in quarters infected with either
bacterium correlated with elevated plasma
levels of LBP (Fig. 3) and were temporally
coincident with increased mammary vascu-
lar permeability (Fig. 5). This finding is
compatible with acute phase induction of
hepatic synthesis of LBP and flux of LBP
from the vascular compartment into the
infected quarters. sCD14 concentrations in
plasma were unable to be determined presum-
ably due to assay interference from plasma
components. Plasma component interference
has been described for other ELISA’s as
well [37]. Therefore, whether the increases
in sCD14 are a result of vascular leakage
remains unknown. Increases in intramam-
mary sCD14 during the course of mastitis
have been proposed to be the result of CD14
shedding from the neutrophil surface [27].
Consistent with this hypothesis, increases
in sCD14 levels (Fig. 9A) following a lag
time paralleled elevations in milk SCC
(Fig. 4B) in quarters infected with either
bacteria.
To our knowledge, the present report is
the first to characterize the innate immune
response to IMI with S. marcescens. A
recent report by Rambeaud et al. [42] char-
acterized a limited set of innate immune
responses to S. uberis strain UT888 includ-
ing milk SCC, TNF-α, IL-1β, and IL-8. The
present study examined all of those factors
following IMI with S. uberis strain 0140
and expanded upon that initial report by
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studying an array of additional responses
including: complement activation; IL-10,
IL-12, and IFN-γ production; changes in the
levels of the host innate recognition acces-
sory molecules sCD14 and LBP; and
changes in mammary vascular permeabil-
ity. The reports also differ in the strain of
S. uberis used to experimentally establish
IMI. Further, Holstein cows used in the
study by Rambeaud et al. [42] were infused
in 2 quarters with 10 500 CFU of S. uberis
whereas those in the present study were
infused in only one quarter with an ~ 50-
fold lower inoculating dose of 220 CFU.
Despite the highly conserved nature of
the innate immune system, the current study
establishes that the temporal responses and
the level of responses elicited by Gram-pos-
itive and Gram-negative bacteria are varia-
ble. The systemic and local innate immune
response to S. marcescens is similar to that
reported for another Gram-negative organ-
ism, E. coli [27, 51]. IMI with either organ-
ism was characterized by rapid and tran-
sient increases in body temperature and the
pro-inflammatory cytokines TNF-α and IL-8.
In contrast, the innate immune response to
S. uberis differed greatly with that reported for
another Gram-positive organism, S. aureus.
In the context of a previous study demon-
strating a complete absence of an IL-8,
TNF-α, and IL-1β response to S. aureus
IMI [45], the current finding that S. uberis
induces the production of these cytokines
suggests that the innate immune response to
distinct Gram-positive bacteria is highly var-
iable. Because the successful control and/or
elimination of bacterial pathogens is medi-
ated, in part, by the nature of the innate
immune response [9], differential host
responses to distinct mastitis-causing path-
ogens may dictate whether IMI’s are acute
and limited or develop into a chronic and
prolonged infectious state.
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